“…Thus, there is an increased incidence of treatment-associated side effects, such as cognitive, hematological, otological, endocrinological, and neurological complications [22, 24, 25]. Syringomyelia related to medulloblastoma is rare (table 1 shows the reported cases), although there have been several reports of syringomyelia secondary to intracranial tumor [6,7,8], mainly of the posterior fossa [3,4,5, 9, 12]. …”